Search / 55 results found

from
to
  • Updated

WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- The U.S. Food and Drug Administration approved Rinvoq (upadacitinib) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older, the manufacturer announced Friday.

  • Updated

TUESDAY, Jan. 18, 2022 (HealthDay News) -- Two years into the pandemic, coronavirus treatments like monoclonal antibodies and antiviral pills have been approved to treat COVID-19, but it's hard to keep track of which ones still work, experts say.

  • Updated

FRIDAY, Jan. 14, 2022 (HealthDay News) -- A three-month sexual abstinence rule for blood donations from sexually active gay and bisexual men should be dropped by the U.S. Food and Drug Administration, critics urge as the country struggles with a blood shortage.

  • Updated

FRIDAY, Jan. 14, 2022 (HealthDay News) -- The nomination of former U.S. Food and Drug Administration head Dr. Robert Califf to again lead the agency now heads to the full Senate for a vote, after a Senate committee on Thursday voted 13-8 for approval.

THURSDAY, Jan. 13, 2022 (HealthDay News) -- Arthritis can keep a cat from doing many of the things that kitties love to do. But now there's hope: The first treatment to ease arthritis pain in cats has been approved by the U.S. Food and Drug Administration.

OXFORD, Ohio and COCONUT CREEK, Fla., Jan. 10, 2022 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF)  ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focusing on discovering and developing new, bespoke, psycho-targeted therapeutics to potentially improve mental and neurological health, today announced that Evan Levine, Chief Executive Officer and Chairman, will present at the H.C. Wainwright Bioconnect Conference.